This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Market Context Stoke (STOK) market analysis \| growth forecasts and trading activity remain in focus. Many traders have ...

Stoke Therapeutics, Inc. (STOK) shares soared 9.4% in the last trading session to close at $12.60. The move was backed by solid volume with far more shares changing hands than in a normal session.

The average one-year price target for Stoke Therapeutics (NasdaqGS:STOK) has been revised to $36.46 / share. This is an increase of 10.42% from the prior estimate of $33.02 dated December 18, 2025.

Short interest in Stoke Therapeutics Inc (NASDAQ:STOK) decreased during the last reporting period, falling from 11.19M to 10.74M. This put 23.69% of the company's publicly available shares short.

) has been revised to $43.96 / share. This is an increase of 12.11% from the prior estimate of $39.21 dated February 21, 2026. The price target is an average of many targets provided by analysts. The ...

Stoke Therapeutics, Inc. (STOK) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.51. This compares to loss of $0.60 per share a year ago. These ...